Skip to main content


Featured Stories

Cover Story
Value-based care is increasingly common in other specialties of medicine, but in dermatology, defining successful patient outcomes may be too variable for this revenue model to be effective.
Janus kinase (JAK) inhibitors are an emerging drug class in dermatology. A further testament to their broad activity and potential importance across all of medicine, JAK inhibitors may be useful in some patients with COVID-19.
Dermatology practices are under pressure to offer telemedicine for patient care and bottom lines. Improvements in teledermatology platforms make incorporation easier than ever before.
Practice Advances
Government declarations enabled telehealth to be, at least temporarily, a commonplace patient care modality. However, physicians should weigh a number of privacy and security factors before implementing telemedicine into their practice.
Understanding the dermatologic signs of COVID-19 will help elucidate whether pernio-toes, papulovesicular lesions, retiform purpura, or another underreported manifestation are legitimate diagnostic features of the disease.
Back to Top